There was continued emphasis on pathogenesis,
management, and prevention of the long-term complications of HIV disease
and its therapies, including cardiovascular disease, renal disease, alterations
in bone metabolism, and vitamin D deficiency, along with a growing focus
on biomarkers to predict development of end-organ disease. Understanding
the elevated risk for non–AIDS-defining malignancies in the HIV-infected
population and optimal management was a focal point of this year’s data.
Finally, the conference provided important information on tuberculosis
coinfection and cryptococcal meningitis